UnitedHealth, WellPoint Earnings Woes Include Higher Medicare Drug Costs

UnitedHealth Group and WellPoint both reported last week that unexpectedly high drug costs in their Medicare plans pressured overall earnings during the first quarter

More from Archive

More from Pink Sheet